Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Infectious Diseases (CID)
A multisociety consensus paper outlines hospital-level strategies to improve sepsis outcomes, emphasizing diagnostic stewardship, antimicrobial optimization, surveillance, infection prevention, and multidisciplinary infrastructure while prioritizing interventions judged most feasible and impactful for broad implementation.
Emergency Medicine September 8th 2026
Journal of the American Academy of Physician Associates (JAAPA)
Neonatal sepsis affects an estimated 22 per 1,000 live births globally and carries significant morbidity risk, with PA-authored CME examining risk stratification, diagnostic sequencing, and antimicrobial stewardship for the practicing provider.
Obstetrics & Gynecology June 18th 2026
A retrospective quasi-experimental study at St. Jude Children’s Research Hospital found that discontinuing empiric antibiotics within 72 hours of febrile neutropenia onset in clinically stable pediatric haploidentical HCT recipients reduced antibiotic exposure by a median of 8 days without significant differences in bloodstream infection, ICU admission, or mortality.
Pediatric Hematology/Oncology June 17th 2026
The American Journal of Nursing (AJN)
The use of a BD Vacutainer Z-tube, which costs approximately $0.25 to $0.50 per tube, represents a highly cost-effective intervention, preventing contamination and potentially saving nearly $11,000 per patient.
Emergency/Trauma Nursing June 10th 2026
Pulmonology Advisor
The 2026 Surviving Sepsis Campaign pediatric guidelines issued 61 recommendations covering infection recognition, hemodynamics, ventilation, and long-term follow-up for children with sepsis or septic shock.
Emergency Medicine June 3rd 2026
Open Forum Infectious Diseases (OFID)
Cotrimoxazole was associated with nearly twice the adverse event rate of fluoroquinolones in a retrospective study of 228 hospitalized men aged 75 or older with urinary tract infections, with acute kidney injury onset occurring at a median of six days post-initiation.
Clinical Pharmacology May 29th 2026